{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:55:49Z","timestamp":1791212149827,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,12,4]],"date-time":"2004-12-04T00:00:00Z","timestamp":1102118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00253-004-1809-x","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T14:10:02Z","timestamp":1102083002000},"page":"151-159","source":"Crossref","is-referenced-by-count":130,"title":["Therapeutic insulins and their large-scale manufacture"],"prefix":"10.1007","volume":"67","author":[{"given":"Gary","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,12,4]]},"reference":[{"key":"CR1","unstructured":"Aventis (2003) Aventis 2003 annual report. Available at http:\/\/www.aventis.com"},{"key":"CR2","first-page":"251","volume":"7","author":"F Banting","year":"1922","unstructured":"Banting F, Best C (1922) The internal secretions of the pancreas. J Lab Clin Med 7:251?266","journal-title":"J Lab Clin Med"},{"issue":"3","key":"CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/diacare.16.3.4","volume":"16","author":"M Bliss","year":"1993","unstructured":"Bliss M (1993) The history of insulin. Diabetes Care 16(3):4?7","journal-title":"Diabetes Care"},{"key":"CR4","first-page":"279","volume":"26","author":"T Blundell","year":"1972","unstructured":"Blundell T, Dodson G, Hodgkin D, Mercola D (1972) Insulin: the structure in the crystal and its reflection in chemistry and biology. Adv Prot Chem 26:279?402","journal-title":"Adv Prot Chem"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/333679a0","volume":"333","author":"J Brange","year":"1988","unstructured":"Brange J, Ribel J, Hansen JF, Dodson G, Hansen MT, Havelund S, Melberg SG, Norris K, Norris L, Snel L, Sorensen AR, Voigt HO (1988) Monomeric insulins obtained by protein engineering and their medical implications. Nature 333:679?682","journal-title":"Nature"},{"issue":"9","key":"CR6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/diacare.13.9.923","volume":"13","author":"J Brange","year":"1990","unstructured":"Brange J, Owens DR, Kang S, Volund A (1990) Monomeric insulins and their experimental and clinical implications. Diabetes Care 13(9):923?954","journal-title":"Diabetes Care"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","volume":"35","author":"G Carino","year":"1999","unstructured":"Carino G, Mathiowitz E (1999) Oral insulin delivery. Adv Drug Del Rev 35:249?257","journal-title":"Adv Drug Del Rev"},{"issue":"1","key":"CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/diacare.27.1.239","volume":"27","author":"WT Cefalu","year":"2004","unstructured":"Cefalu WT (2004) Concepts, strategies and feasibility of noninvasive insulin delivery. Diabetes Care 27(1):239?246","journal-title":"Diabetes Care"},{"issue":"3","key":"CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2337\/diacare.16.3.133","volume":"16","author":"R Chance","year":"1993","unstructured":"Chance R, Frank B (1993) Research, development production and safety of biosynthetic human insulin. Diabetes Care 16(3):133?142","journal-title":"Diabetes Care"},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"Chance R, Glazer N, Wishner K (1999) Insulin Lispro (Humalog). In: Walsh G, Murphy B (eds) Biopharmaceuticals, an industrial perspective. Kluwer, Dordrecht pp 149?172","DOI":"10.1007\/978-94-017-0926-2_6"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0969-2126(01)00195-2","volume":"3","author":"E Ciszak","year":"1995","unstructured":"Ciszak E, Beals M, Frank BH (1995) Role of C-terminal B chain residues in insulin assembly: the structure of hexameric LysB28 ProB29 human insulin. Structure 3:615?622","journal-title":"Structure"},{"issue":"1","key":"CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2003.07.021","volume":"53","author":"S Clement","year":"2004","unstructured":"Clement S, Dandona P, Still JG, Kosutic G (2004) Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I\/II clinical trial. Metabolism 53(1):54?58","journal-title":"Metabolism"},{"issue":"5","key":"CR13","first-page":"265","volume":"6","author":"S Efrat","year":"2004","unstructured":"Efrat S (2004) Generation of insulin producing cells from stem cells for cell replacement therapy of type 1 diabetes. Isr Med Assoc J 6(5):265?267","journal-title":"Isr Med Assoc J"},{"key":"CR14","unstructured":"Frank B (1981) The production of human proinsulin and its transformation to human insulin and C peptide. In: Rich D, Gross E (eds) Proceedings of the seventh American peptide symposium on peptidases: synthesis-structure-function. Pierce Chemical, Rockford, USA, pp 729?738"},{"issue":"Suppl 1","key":"CR15","first-page":"423A","volume":"40","author":"B Frank","year":"1991","unstructured":"Frank B (1991) Manupilation of the position of proline in the B chain produced monomeric insulins. Diabetes 40[Suppl 1]:423A","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"CR16","first-page":"A189","volume":"38","author":"B Frank","year":"1995","unstructured":"Frank B, Baker J, Bakaysa D (1995) Lys B28 Pro B29 human insulin (insulin lispro): solution properties of a rapid acting insulin. Diabetologia 38[Suppl 1]:A189","journal-title":"Diabetologia"},{"issue":"12","key":"CR17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-2007-1001766","volume":"26","author":"JA Galloway","year":"1994","unstructured":"Galloway JA, Chance RE (1994) Improving insulin therapy: achievements and challenges. Horm Metab Res 26(12):591?598","journal-title":"Horm Metab Res"},{"key":"CR18","unstructured":"Generex (2004) Oralin product information. Available at http:\/\/www.generex.com"},{"issue":"3","key":"CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1081\/DDC-120018199","volume":"29","author":"NM Ghilzai","year":"2003","unstructured":"Ghilzai NM (2003) New developments in insulin delivery. Drug Dev Ind Pharm 29(3):253?265","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"CR20","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1023\/B:PHAM.0000036926.54824.37","volume":"21","author":"S Havelund","year":"2004","unstructured":"Havelund S, Plum A, Ribel U, Jonassen I, Volund A, Markussen J, Kurtzhals P (2004) The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin. Pharm Res 21(8):1498?1504","journal-title":"Pharm Res"},{"issue":"6","key":"CR21","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diabetes.53.6.1614","volume":"53","author":"T Heise","year":"2004","unstructured":"Heise T, Nosek L, Ronn B, Endhal L, Heinemann L, Kapitza C (2004) Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 53(6):1614?1620","journal-title":"Diabetes"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(98)00073-8","volume":"35","author":"M Hinchcliffe","year":"1999","unstructured":"Hinchcliffe M, Illum L (1999) Intranasal insulin delivery and therapy. Adv Drug Del Rev 35:199?234","journal-title":"Adv Drug Del Rev"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1021\/bi00617a023","volume":"17","author":"GA Homandberg","year":"1978","unstructured":"Homandberg GA, Mattis J, Llaskowski M (1978) Synthesis of peptide bonds by proteinases. Addition of organic solvents shifts peptide bond equilibria towards synthesis. Biochemistry 17:5220?5227","journal-title":"Biochemistry"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0140-6736(90)90602-2","volume":"335","author":"S Kang","year":"1990","unstructured":"Kang S, Owens DR, Vora JP, Brange J (1990) Comparison of insulin analog B9ASPB27GLU and soluble human insulin in insulin-treated diabetics. Lancet 335:303?306","journal-title":"Lancet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2337\/diacare.14.7.571","volume":"14","author":"S Kang","year":"1991","unstructured":"Kang S, Creagh F, Peters J, Brange J, Volund A, Owens D (1991) Comparison of subcutaneous soluble human insulin and insulin analogues on meal-related plasma glucose excursions in type-1 diabetic subjects. Diabetes Care 14:571?577","journal-title":"Diabetes Care"},{"issue":"4","key":"CR26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1089\/1520915041705974","volume":"6","author":"C Kapitza","year":"2004","unstructured":"Kapitza C, Hompesch M, Scharling B, Heise T, (2004) Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin. Diabetes Technol Ther 6(4):466?472","journal-title":"Diabetes Technol Ther"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002530000402","volume":"54","author":"T Kjeldsen","year":"2000","unstructured":"Kjeldsen T (2000) Yeast secretory expression of insulin precursors. Appl Microbiol Biotechnol 54:277?286","journal-title":"Appl Microbiol Biotechnol"},{"issue":"21","key":"CR28","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.C200137200","volume":"277","author":"T Kjeldsen","year":"2002","unstructured":"Kjeldsen T, Ludvigsen S, Diers I, Balschmidt P, Sorensen A, Kaarsholm N (2002) Engineering-enhanced protein secretory expression in yeast with application to insulin. J Biol Chem 277(21):18245?18248","journal-title":"J Biol Chem"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0169-409X(91)90030-G","volume":"6","author":"J Kost","year":"1991","unstructured":"Kost J, Langer R (1991) Responsive polymeric delivery systems. Adv Drug Del Rev 6:19?50","journal-title":"Adv Drug Del Rev"},{"issue":"12","key":"CR30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1021\/js9701768","volume":"86","author":"P Kurtzhals","year":"1997","unstructured":"Kurtzhals P, Havelund S, Jonassen S, Markussen J (1997) Effect of fatty acids and selected drugs on the albumin binding of a long acting, acylated insulin analogue. J Pharm Sci 86(12):1365?1368","journal-title":"J Pharm Sci"},{"issue":"6","key":"CR31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","volume":"49","author":"P Kurtzhals","year":"2000","unstructured":"Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T, (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49(6):999?1005","journal-title":"Diabetes"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(00)00056-9","volume":"42","author":"MK Lee","year":"2000","unstructured":"Lee MK, Bae YH (2000) Cell transplantation for endocrine disorders. Adv Drug Del Rev 42:103?120","journal-title":"Adv Drug Del Rev"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1357-4310(98)01425-7","volume":"5","author":"F Levene","year":"1999","unstructured":"Levene F, Leibowitz G (1999) Towards gene therapy of diabetes mellitus. Mol Med Today 5:165?171","journal-title":"Mol Med Today"},{"key":"CR34","unstructured":"Lilly (2003) Lilly 2003 annual report. Available at http:\/\/www.lilly.com"},{"key":"CR35","unstructured":"Markussen J (1980) Process for preparing insulin esters. United Kingdom patent application GB 2069502 A"},{"key":"CR36","first-page":"302","volume":"21","author":"J Markussen","year":"1981","unstructured":"Markussen J, Jorgensen K, Thim L, Damgaard U, Sorensen E, Dodson G, Chawdhury F (1981) Human monocomponent insulin: chemistry and characteristics of human insulin. Diabetologia 21:302","journal-title":"Diabetologia"},{"key":"CR37","first-page":"568A","volume":"29","author":"J Markussen","year":"1986","unstructured":"Markussen J, Damgaard U, Diers I, Fiil N, Hansen M, Lassen P, Norris F, Norris P, Schou O, Snel L, Thim L, Voigt H (1986) Biosynthesis of human insulin in yeast via single chain precursors. Diabetologia 29:568A?569A","journal-title":"Diabetologia"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/280412a0","volume":"280","author":"K Morihara","year":"1979","unstructured":"Morihara K, Oka T, Tsuzukih H (1979) Semi synthesis of human insulin by trypsin-catalyzed replacement of Ala-B30 by Thr in porcine insulin. Nature 280:412?413","journal-title":"Nature"},{"issue":"10","key":"CR39","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1600-6143.2003.00221.x","volume":"3","author":"PC Nett","year":"2003","unstructured":"Nett PC, Sollinger HW, Alam T (2003) Hepatic insulin gene therapy in insulin-dependent diabetes mellitus. Am J Transplant 3(10):1197?1203","journal-title":"Am J Transplant"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/187483a0","volume":"187","author":"S Nicol","year":"1960","unstructured":"Nicol S, Smith M (1960) Amino acid sequence of human insulin. Nature 187:483?485","journal-title":"Nature"},{"key":"CR41","unstructured":"Novo (2003) Novo nordisk 2003 annual report. Available at http:\/\/www.novonordisk.com"},{"key":"CR42","unstructured":"Owens DR, Vora JP, Dolben J (1991) Human insulin and beyond: semisynthesis and recombinant DNA technology reviewed. In: Pickup JC (ed) Biotechnology of insulin therapy. Blackwell, Oxford, pp 24?41"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(01)05842-1","volume":"358","author":"DR Owens","year":"2001","unstructured":"Owens DR, Zinman B, Bolli G (2001) Insulins today and beyond. Lancet 358:739?746","journal-title":"Lancet"},{"issue":"11","key":"CR44","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1464-5491.2003.01076.x","volume":"20","author":"DR Owens","year":"2003","unstructured":"Owens DR, Zinman B, Bolli G (2003). Alternative routes of insulin delivery. Diabet Med 20(11):886?898","journal-title":"Diabet Med"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00113-L","volume":"19","author":"J Patton","year":"1996","unstructured":"Patton J (1996) Mechanisms of macromolecule absorption by the lungs. Adv Drug Del Rev 19:3?36","journal-title":"Adv Drug Del Rev"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(98)00074-X","volume":"35","author":"J Patton","year":"1999","unstructured":"Patton J, Bukar J, Nagarajan S (1999) Inhaled insulin. Adv Drug Del Rev 35:235?247","journal-title":"Adv Drug Del Rev"},{"issue":"3?4","key":"CR47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.trim.2003.12.011","volume":"12","author":"AB Peck","year":"2004","unstructured":"Peck AB, Ramiya V (2004) In vitro generation of surrogate islets from adult stem cells. Transpl Immunol 12(3?4):259?272","journal-title":"Transpl Immunol"},{"issue":"6","key":"CR48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1359-6446(01)01962-6","volume":"20","author":"O Pillai","year":"2001","unstructured":"Pillai O, Panchagnula R (2001) Insulin therapies?past, present and future. Drug Discov Today 20(6):1056?1061","journal-title":"Drug Discov Today"},{"issue":"4","key":"CR49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF02348079","volume":"41","author":"E Roche","year":"2003","unstructured":"Roche E, Sepulcre MP, Ensenat-Waser R, Maestre I, Reig JA, Soria B (2003) Bio-engineering insulin-secreting cells from embryonic stem cells: a review of progress. Med Biol Eng Comput 41(4):384?391","journal-title":"Med Biol Eng Comput"},{"issue":"II","key":"CR50","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1042\/bj0281592","volume":"28","author":"D Scott","year":"1934","unstructured":"Scott D (1934) Crystalline insulin. Biochem J 28(II):1592?1602","journal-title":"Biochem J"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/hlca.19740570839","volume":"57","author":"P Sieber","year":"1974","unstructured":"Sieber P, Kamber B, Hartmann A, Johl A, Riniker B, Rittel W (1974) Total synthese von human insulin unter gezielter bildung der disulfid bindungen. Helv Chim Acta 57:2617?2621","journal-title":"Helv Chim Acta"},{"issue":"2","key":"CR52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2003.08.011","volume":"56","author":"GM Steil","year":"2004","unstructured":"Steil GM, Panteleon AE, Rebrin K (2004) Cloosed-loop insulin delivery?the path to physiological glucose control. Adv Drug Del Rev 56(2):125?144","journal-title":"Adv Drug Del Rev"},{"key":"CR53","unstructured":"Sutcliffe J, Duin N (1992) A history of medicine. Barnes and Noble, USA, pp 104?105"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1073\/pnas.83.18.6766","volume":"83","author":"L Thim","year":"1986","unstructured":"Thim L, Hansen MT, Norris K, Hoegh I, Boel E, Forstrom J, Ammerer G, Fiil NP (1986) Secretion and processing of insulin precursors in yeast. PNAS 83:6766?6770","journal-title":"PNAS"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.297.6658.1236","volume":"297","author":"JP Vora","year":"1988","unstructured":"Vora JP, Owens DR, Dolben J, Atiea TA, Dean JD, Kang S, Burch A, Brange J (1988) Recombinant DNA derived monomeric insulin analogue. Comparison with soluble human insulin in normal subjects. Br Med J 297:1236?1239","journal-title":"Br Med J"},{"key":"CR56","unstructured":"Walsh G (1998) Biopharmaceuticals: biochemistry and biotechnology. Wiley, Chichester"},{"key":"CR57","unstructured":"WHO (2004) Diabetes action report. Available at http:\/\/www.who.int"},{"issue":"2","key":"CR58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4914(02)02279-7","volume":"8","author":"JW Yoon","year":"2002","unstructured":"Yoon JW, Jun HS (2002) Recent advances in gene therapy for type 1 diabetes. Trends Mol Med 8(2):62?68","journal-title":"Trends Mol Med"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-004-1809-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-004-1809-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-004-1809-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:05:42Z","timestamp":1558710342000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-004-1809-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["1809"],"URL":"https:\/\/doi.org\/10.1007\/s00253-004-1809-x","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,4]]}}}